The VEPRO Trial: A Cross-Over Randomised Controlled Trial Comparing 2 Corrective Lenses for Patients With Presbyopia
VEPRO
1 other identifier
interventional
127
1 country
1
Brief Summary
The VEPRO trial is a cross-over randomised controlled trial comparing 2 corrective lenses for patients with presbyopia. The aim of the study is to compare the effectiveness of two corrective lenses: an old generation (Varilux Comfort Orma Crizal) and a new generation (Varilux Panamic Orma Crizal) of corrective lenses prescribed in presbyopia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
March 6, 2008
CompletedFirst Posted
Study publicly available on registry
March 13, 2008
CompletedMarch 13, 2008
March 1, 2008
11 months
March 6, 2008
March 12, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
patient preference for a corrective lens
8 weeks
Secondary Outcomes (1)
subjective measures of different areas of visual performance.
8 weeks
Study Arms (2)
1
EXPERIMENTAL2
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- age 43 to 60 years old
- outpatients wearing corrective lenses for presbyopia, referred to an optician within the last 6 months for a change in their optical correction
- associated hyperopia or astigmatism, the required correction had to be ≤ 3 dioptres in that case
- understanding, speaking French and able to answer a questionnaire
You may not qualify if:
- first prescription of corrective lenses for presbyopia
- associated strabism
- associated amblyopia
- orthoptics therapy
- associated anisometropia \> 1.5 dioptres
- patients treated for diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Santéclairlead
Study Sites (1)
INSERM, U738, Paris, France ; Université Paris 7 Denis Diderot, UFR de Médecine, Paris, France ; AP-HP, Hôpital Bichat, Département d'Epidémiologie, Biostatistique et Recherche Clinique
Paris, 75018, France
Related Publications (1)
Boutron I, Touizer C, Pitrou I, Roy C, Ravaud P. The VEPRO trial: a cross-over randomised controlled trial comparing 2 progressive lenses for patients with presbyopia. Trials. 2008 Sep 19;9:54. doi: 10.1186/1745-6215-9-54.
PMID: 18803826DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 6, 2008
First Posted
March 13, 2008
Study Start
February 1, 2006
Primary Completion
January 1, 2007
Study Completion
January 1, 2007
Last Updated
March 13, 2008
Record last verified: 2008-03